ArticleNeuro-oncology2014

JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.

Qifan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.